# 119-hr-5629: To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.

119-hr-5629, To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect., is a 119th Congress bill sponsored by Rep. Houchin, Erin [R-IN-9] (R-IN); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-hr-5629
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-5629
- Congress: 119
- Title: To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.
- Status: introduced
- Introduced: 2025-09-30
- Sponsor: Rep. Houchin, Erin [R-IN-9] (R-IN)
- Cosponsors: 0
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**Removes most of HHS's 2024 final rule on medications for opioid use disorder but preserves accreditation changes for opioid treatment programs.** This bill would void the final rule published at 89 Fed. Reg. 7549 (Feb. 2, 2024) except for the portions that modify Subpart B of Part 8 of Title 42 of the Code of Federal Regulations. - People in treatment and families: Accreditation changes for opioid treatment programs remain in place, while the rule's other new policies on medications for opioid use disorder would not apply. - Opioid treatment programs and providers: Would need to follow the modified Subpart B accreditation rules but would not be subject to the final rule's other medication-related requirements. - HHS and federal regulators: Would be limited to enforcing only the accreditation provisions from 89 Fed. Reg. 7549, with the rest of that final rule vacated.

## Provisions PRIA read

- Cancel opioid treatment rule, keep accreditation: cost, medium. If enacted, this bill would cancel a federal rule on medicines for opioid use disorder (89 Fed. Reg. 7549; Feb 2, 2024). Only the parts about accrediting opioid treatment programs would stay in place. Clinics and doctors would no longer follow the rest of that rule. Patients seeking these medicines…

## Related bills

- 119-hr-137: TCJA Permanency Act
- 119-hr-2725: Affordable Housing Credit Improvement Act of 2025
- 119-hr-2570: Maximum Pressure Act
- 119-hr-9960: Higher Education Access and Success for Homeless and Foster Youth Act of 2026
- 119-hr-9363: AI Security and Innovation Act
- 119-hr-7325: Truth and Healing Commission on Indian Boarding School Policies Act of 2026

## Sources
- [119-hr-5629 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/5629)

## Related
- [119-hr-137: TCJA Permanency Act](https://policyrisk.com/legislation/119-hr-137)
- [119-hr-2725: Affordable Housing Credit Improvement Act of 2025](https://policyrisk.com/legislation/119-hr-2725)
- [119-hr-2570: Maximum Pressure Act](https://policyrisk.com/legislation/119-hr-2570)
- [119-hr-9960: Higher Education Access and Success for Homeless and Foster Youth Act of 2026](https://policyrisk.com/legislation/119-hr-9960)
- [119-hr-9363: AI Security and Innovation Act](https://policyrisk.com/legislation/119-hr-9363)
- [119-hr-7325: Truth and Healing Commission on Indian Boarding School Policies Act of 2026](https://policyrisk.com/legislation/119-hr-7325)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-5629 (as of 2026-04-21).